Variant report
Variant | nsv971154 |
---|---|
Chromosome Location | chr7:27390702-27397127 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:12)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:12 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr7:27396620-27396770 | GM12801 | blood: | n/a | n/a |
2 | NFIC | chr7:27391819-27392188 | ECC-1 | luminal epithelium: | n/a | n/a |
3 | NRF1 | chr7:27394978-27395000 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | POLR2A | chr7:27395585-27395659 | Hela-S3 | cervix: | n/a | n/a |
5 | POLR2A | chr7:27395706-27395726 | Hela-S3 | cervix: | n/a | n/a |
6 | POLR2A | chr7:27390735-27391149 | H1-neurons | neurons: | n/a | n/a |
7 | REST | chr7:27394741-27395477 | H1-neurons | neurons: | n/a | n/a |
8 | REST | chr7:27394916-27395423 | H1-neurons | neurons: | n/a | n/a |
9 | SPI1 | chr7:27391395-27391728 | HL-60 | blood: | n/a | n/a |
10 | SPI1 | chr7:27391369-27391712 | HL-60 | blood: | n/a | n/a |
11 | USF1 | chr7:27393022-27393203 | SK-N-SH_RA | brain: | n/a | n/a |
12 | USF2 | chr7:27393043-27393303 | HepG2 | liver: | n/a | n/a |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:27391102..27394660-chr7:27401412..27404075,3 | MCF-7 | breast: | |
2 | chr7:27385251..27387696-chr7:27388686..27392238,3 | K562 | blood: | |
3 | chr7:27389345..27391208-chr7:27395433..27397427,2 | MCF-7 | breast: | |
4 | chr7:27385251..27387696-chr7:27388686..27391421,2 | K562 | blood: | |
5 | chr7:27396809..27399657-chr7:27404477..27407398,2 | MCF-7 | breast: | |
6 | chr7:27396768..27399494-chr7:27410784..27413777,2 | MCF-7 | breast: | |
7 | chr7:27393165..27395076-chr7:27476139..27478551,2 | K562 | blood: | |
8 | chr7:27389345..27391208-chr7:27395433..27397427,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000224322 | TF binding region |
ENSG00000224322 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183748713 | chr7:27390734-27390735 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs578184698 | chr7:27390754-27390755 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs545322771 | chr7:27390850-27390851 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563735944 | chr7:27390861-27390862 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs4722691 | chr7:27390865-27390866 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs188076527 | chr7:27390894-27390895 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs181360689 | chr7:27390901-27390902 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs529048740 | chr7:27390929-27390930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs6462010 | chr7:27390953-27390954 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs11563983 | chr7:27390956-27390957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs369023393 | chr7:27390979-27390980 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs559316984 | chr7:27390992-27390993 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs372261231 | chr7:27391004-27391005 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs145332835 | chr7:27391100-27391101 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs184858450 | chr7:27391103-27391104 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs570028018 | chr7:27391112-27391113 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs530934113 | chr7:27391121-27391122 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs549183832 | chr7:27391171-27391172 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs722562 | chr7:27391186-27391187 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs189409910 | chr7:27391198-27391199 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs368688089 | chr7:27391242-27391243 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs377057532 | chr7:27391243-27391244 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs28398483 | chr7:27391258-27391259 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs75435028 | chr7:27391278-27391279 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs564810779 | chr7:27391283-27391284 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs575584866 | chr7:27391284-27391285 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs150379229 | chr7:27391331-27391332 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs564196229 | chr7:27391421-27391422 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs117982236 | chr7:27391432-27391433 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs181935388 | chr7:27391462-27391463 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs560873328 | chr7:27391494-27391495 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs186639452 | chr7:27391550-27391551 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs560593714 | chr7:27391563-27391564 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs722563 | chr7:27391569-27391570 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs4722692 | chr7:27391584-27391585 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs4719890 | chr7:27391639-27391640 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs375720280 | chr7:27391684-27391685 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs10266399 | chr7:27391685-27391686 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs563599647 | chr7:27391712-27391713 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs530893998 | chr7:27391719-27391720 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs7777464 | chr7:27391727-27391728 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs536612944 | chr7:27391766-27391767 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs567582183 | chr7:27391771-27391772 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs374133086 | chr7:27391799-27391800 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs73282158 | chr7:27391833-27391834 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs571465689 | chr7:27391964-27391965 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs538850486 | chr7:27391993-27391994 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs181845700 | chr7:27392001-27392002 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs557022523 | chr7:27392016-27392017 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs10282366 | chr7:27392031-27392032 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Cancer | 21183584 | CNVD |
abnormal development | 18461090 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Lung cancer | 17086460 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:27390200-27391000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr7:27390200-27396000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr7:27390800-27392200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
4 | chr7:27391000-27391600 | Flanking Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr7:27391600-27392000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr7:27393400-27394200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr7:27394200-27403400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr7:27396000-27396200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr7:27396200-27396600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr7:27396600-27397800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |